| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/17/2023 | 18.72% | UBS | $142 → $113 | Maintains | Buy |
| 10/11/2023 | 9.26% | Truist Securities | $115 → $104 | Maintains | Hold |
| 08/07/2023 | 49.18% | UBS | $100 → $142 | Upgrades | Neutral → Buy |
| 07/13/2023 | 20.82% | Truist Securities | $100 → $115 | Maintains | Hold |
| 05/15/2023 | 5.06% | Bernstein | $88 → $100 | Maintains | Market Perform |
| 05/09/2023 | 18.72% | Deutsche Bank | $85 → $113 | Maintains | Hold |
| 05/09/2023 | 5.06% | Truist Securities | $90 → $100 | Maintains | Hold |
| 05/09/2023 | 2.96% | TD Cowen | $90 → $98 | Maintains | Market Perform |
| 05/09/2023 | 0.86% | B of A Securities | $86 → $96 | Maintains | Underperform |
| 03/07/2023 | — | Bernstein | Reinstates | → Market Perform | |
| 02/23/2023 | -5.45% | Cowen & Co. | $76 → $90 | Maintains | Outperform |
| 02/23/2023 | -5.45% | Truist Securities | $84 → $90 | Maintains | Hold |
| 10/31/2022 | -21.21% | Truist Securities | $90 → $75 | Maintains | Hold |
| 10/31/2022 | -14.9% | Barclays | $103 → $81 | Maintains | Equal-Weight |
| 10/31/2022 | -22.26% | UBS | $117 → $74 | Downgrades | Buy → Neutral |
| 08/19/2022 | 22.92% | UBS | $106 → $117 | Upgrades | Neutral → Buy |
| 08/04/2022 | 8.21% | Barclays | $128 → $103 | Maintains | Equal-Weight |
| 08/02/2022 | 1.91% | Deutsche Bank | $150 → $97 | Maintains | Buy |
| 06/22/2022 | -5.45% | Truist Securities | $110 → $90 | Maintains | Hold |
| 01/05/2022 | 31.32% | Truist Securities | $114 → $125 | Maintains | Hold |
| 10/29/2021 | 16.62% | RBC Capital | $113 → $111 | Maintains | Sector Perform |
| 10/13/2021 | 31.32% | Truist Securities | $145 → $125 | Maintains | Hold |
| 09/10/2021 | 52.33% | Cowen & Co. | → $145 | Initiates Coverage On | → Market Perform |
| 08/12/2021 | 53.39% | Barclays | $135 → $146 | Downgrades | Overweight → Equal-Weight |
| 07/19/2021 | 117.47% | Deutsche Bank | $150 → $207 | Maintains | Buy |
| 03/26/2021 | 23.97% | B of A Securities | $127 → $118 | Downgrades | Neutral → Underperform |
| 01/05/2021 | 33.42% | B of A Securities | → $127 | Downgrades | Buy → Neutral |
| 05/06/2020 | -5.45% | SunTrust Robinson Humphrey | $82 → $90 | Maintains | Hold |
| 04/13/2020 | -13.85% | SunTrust Robinson Humphrey | $90 → $82 | Maintains | Hold |
| 01/24/2020 | 1.91% | Goldman Sachs | $72 → $97 | Upgrades | Neutral → Buy |
| 12/20/2019 | -21.21% | JP Morgan | $65 → $75 | Maintains | Neutral |
| 12/18/2019 | -15.95% | SunTrust Robinson Humphrey | $72 → $80 | Maintains | Hold |
| 11/19/2019 | -17% | Barclays | $68 → $79 | Maintains | Overweight |
| 11/07/2019 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 11/06/2019 | -31.71% | Baird | $63 → $65 | Maintains | Neutral |
| 09/11/2019 | — | William Blair | Downgrades | Outperform → Market Perform | |
| 08/22/2019 | -36.96% | UBS | $61 → $60 | Maintains | Neutral |
| 07/26/2019 | -31.71% | Baird | $70 → $65 | Downgrades | Outperform → Neutral |
| 05/09/2019 | -30.66% | Deutsche Bank | $68 → $66 | Maintains | Buy |
| 01/08/2019 | -38.02% | UBS | $64 → $59 | Upgrades | Sell → Neutral |
| 01/03/2019 | -36.96% | Deutsche Bank | → $60 | Initiates Coverage On | → Buy |
| 12/14/2018 | -26.46% | Barclays | → $70 | Initiates Coverage On | → Overweight |
| 11/28/2018 | -26.46% | Raymond James | → $70 | Upgrades | Market Perform → Outperform |
What is the target price for DaVita (DVA)?
The latest price target for DaVita (NYSE: DVA) was reported by UBS on November 17, 2023. The analyst firm set a price target for $113.00 expecting DVA to rise to within 12 months (a possible 18.72% upside). 12 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for DaVita (DVA)?
The latest analyst rating for DaVita (NYSE: DVA) was provided by UBS, and DaVita maintained their buy rating.
When is the next analyst rating going to be posted or updated for DaVita (DVA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of DaVita, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for DaVita was filed on November 17, 2023 so you should expect the next rating to be made available sometime around November 17, 2024.
Is the Analyst Rating DaVita (DVA) correct?
While ratings are subjective and will change, the latest DaVita (DVA) rating was a maintained with a price target of $142.00 to $113.00. The current price DaVita (DVA) is trading at is $95.19, which is out of the analyst's predicted range.